Chemed (NYSE:CHE) Raised to Buy at StockNews.com

Chemed (NYSE:CHE – Get Free Report) was upgraded by stock analysts at StockNews.com from a “hold” rating to a “buy” rating in a note issued to investors on Saturday. Other equities research analysts have also issued research reports about the company. Oppenheimer lifted their price objective on Chemed from $625.00 to $650.00 and gave the […]

Related Keywords

Canada ,United States ,Wellington ,New Zealand General ,New Zealand ,Spencers Lee ,Michaeld Witzeman , ,Chemed Corporation ,Royal Bank ,Impax Asset Management Group ,Kayne Anderson Rudnick Investment Management ,Wellington Management Group ,Jpmorgan Chase Co ,Get Free Report ,Anderson Rudnick Investment Management ,Management Group ,Asset Management Group ,Chemed Daily ,Schemed ,Nyse Che ,Oche ,Medical ,16359r10 ,Upgrade ,Stocknews Com ,